[Reproducibility of Acute Captopril-induced Renal Insufficiency with Enalapril]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1984 Jan 2

PMID 6321850

Citations 2

Authors

W Cremer

Affiliations

Soon will be listed here.

Abstract

In this case we are reporting on a patient suffering from malignant renovascular hypertension and chronic renal failure due to occlusion of both renal arteries. The acute renal insufficiency after Captopril and later on after Enalapril treatment was fully reversible. We believe that the acute reversible renal insufficiency was caused by the blockage of glomerular autoregulation depending on Angiotensin II.

Citing Articles

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Todd P, Heel R Drugs. 1986; 31(3):198-248.

PMID: 3011386 DOI: 10.2165/00003495-198631030-00002.

Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril.

Rucinska E, Small R, Mulcahy W, Snyder D, Rodel P, Rush J Med Toxicol Adverse Drug Exp. 1989; 4(2):144-52.

PMID: 2541310 DOI: 10.1007/BF03259909.

References

Collste P, Haglund K, Lundgren G, Magnusson G, Ostman J . Reversible renal failure during treatment with captopril. Br Med J. 1979; 2(6190):612-3. PMC: 1596482. DOI: 10.1136/bmj.2.6190.612-c. View

Curtis J, Luke R, Whelchel J, Diethelm A, Jones P, DUSTAN H . Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med. 1983; 308(7):377-81. DOI: 10.1056/NEJM198302173080707. View

Farrow P, Wilkinson R . Reversible renal failure during treatment with captopril. Br Med J. 1979; 1(6179):1680. PMC: 1599243. DOI: 10.1136/bmj.1.6179.1680. View

Davalos M, Frega N, Saker B, Leaf A . Effect of exogenous and endogenous angiotensin II in the isolated perfused rat kidney. Am J Physiol. 1978; 235(6):F605-10. DOI: 10.1152/ajprenal.1978.235.6.F605. View

Kindler J, Konrads A, MEURER K, Sieberth H . [Progressive reversible kidney insufficiency after blood pressure reduction with captopril]. Internist (Berl). 1981; 22(6):360-3. View

Grossman A, Eckland D, Price P, Edwards C . Captopril: reversible renal failure with severe hyperkalaemia. Lancet. 1980; 1(8170):712. View

Hricik D, Browning P, Kopelman R, Goorno W, Madias N, Dzau V . Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983; 308(7):373-6. DOI: 10.1056/NEJM198302173080706. View

. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmacol. 1982; 14 Suppl 2:97S-101S. PMC: 1427530. View

BLYTHE W . Captopril and renal autoregulation. N Engl J Med. 1983; 308(7):390-1. DOI: 10.1056/NEJM198302173080709. View

10.

. Symposium on angiotensin-converting enzyme inhibition: a developing concept. Am J Cardiol. 1982; 49(6):1381-579. View

11.

Brunner D, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H . Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Br J Clin Pharmacol. 1981; 11(5):461-7. PMC: 1401601. DOI: 10.1111/j.1365-2125.1981.tb01151.x. View

12.

Frega N, Davalos M, Leaf A . Effect of endogenous angiotensin on the efferent glomerular arteriole of rat kidney. Kidney Int. 1980; 18(3):323-7. DOI: 10.1038/ki.1980.142. View

13.

Gross D, Sweet C, Ulm E, Backlund E, MORRIS A, Weitz D . Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. J Pharmacol Exp Ther. 1981; 216(3):552-7. View

14.

Helmchen U, Grone H, Kirchertz E, Bader H, Bohle R, Kneissler U . Contrasting renal effects of different antihypertensive agents in hypertensive rats with bilaterally constricted renal arteries. Kidney Int Suppl. 1982; 12:S198-205. View

15.

Hall J, GUYTON A, Jackson T, Coleman T, Lohmeier T, Trippodo N . Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol. 1977; 233(5):F366-72. DOI: 10.1152/ajprenal.1977.233.5.F366. View

16.

Cremer W . [Captopril and diuretics]. MMW Munch Med Wochenschr. 1982; 124(47):1067-9. View

17.

Biollaz J, Burnier M, Turini G, Brunner D, Porchet M, Gomez H . Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I. Clin Pharmacol Ther. 1981; 29(5):665-70. DOI: 10.1038/clpt.1981.92. View

18.

Burnier M, Biollaz J, Brunner H, Turini G, Gavras H . Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril. Am J Cardiol. 1982; 49(6):1550-1. DOI: 10.1016/0002-9149(82)90386-1. View

19.

Woodhouse K, Farrow P, Wilkinson R . Reversible renal failure during treatment with captopril. Br Med J. 1979; 2(6198):1146-7. PMC: 1596951. DOI: 10.1136/bmj.2.6198.1146-d. View

20.

Navar L, LaGrange R, Bell P, Thomas C, Ploth D . Glomerular and renal hemodynamics during converting enzyme inhibition (SQ20,881) in the dog. Hypertension. 1979; 1(4):371-7. DOI: 10.1161/01.hyp.1.4.371. View